Mometasone Furoate Cream 1mg/g Malta - Engels - Medicines Authority

mometasone furoate cream 1mg/g

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - mometasone furoate - cream - mometasone furoate 0.1 % (w/w) - corticosteroids, dermatological preparations

Mometasone Furoate Cream 0.1%w/w Malta - Engels - Medicines Authority

mometasone furoate cream 0.1%w/w

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - mometasone furoate - cream - mometasone furoate 0.1 % (w/w) - corticosteroids, dermatological preparations

Mometasone Furoate Ointment 0.1%w/w Malta - Engels - Medicines Authority

mometasone furoate ointment 0.1%w/w

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - mometasone furoate - ointment - mometasone furoate 0.1 % (w/w) - corticosteroids, dermatological preparations

ELOCON mometasone furoate 1mg/g lotion bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

elocon mometasone furoate 1mg/g lotion bottle

organon pharma pty ltd - mometasone furoate, quantity: 1 mg/g - lotion - excipient ingredients: isopropyl alcohol; phosphoric acid; hyprolose; propylene glycol; monobasic sodium phosphate dihydrate; purified water - indications: elocon lotion (mometasone furoate) is indicated for-: short-term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, such as psoriasis and atopic dermatitis. - the short-term use for scalp psoriasis and seborrhoeic dermatitis.

ENERZAIR BREEZHALER 114/46/136 indacaterol/glycopyrronium/mometasone furoate 114/46/136 microgram powder for inhalation in capsule with inhaler Australië - Engels - Department of Health (Therapeutic Goods Administration)

enerzair breezhaler 114/46/136 indacaterol/glycopyrronium/mometasone furoate 114/46/136 microgram powder for inhalation in capsule with inhaler

novartis pharmaceuticals australia pty ltd - indacaterol acetate, quantity: 173 microgram (equivalent: indacaterol, qty 150 microgram); mometasone furoate, quantity: 160 microgram; glycopyrronium bromide, quantity: 63 microgram (equivalent: glycopyrronium, qty 50 microgram) - capsule, hard - excipient ingredients: lactose monohydrate; magnesium stearate - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

ENERZAIR BREEZHALER 114/46/68 indacaterol/glycopyrronium/mometasone furoate 114/46/68 microgram powder for inhalation in capsule with inhaler Australië - Engels - Department of Health (Therapeutic Goods Administration)

enerzair breezhaler 114/46/68 indacaterol/glycopyrronium/mometasone furoate 114/46/68 microgram powder for inhalation in capsule with inhaler

novartis pharmaceuticals australia pty ltd - glycopyrronium bromide, quantity: 63 microgram (equivalent: glycopyrronium, qty 50 microgram); mometasone furoate, quantity: 80 microgram; indacaterol acetate, quantity: 173 microgram (equivalent: indacaterol, qty 150 microgram) - capsule, hard - excipient ingredients: lactose monohydrate; magnesium stearate - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

MOMETASONE-ZP mometasone furoate 0.1% w/w lotion bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

mometasone-zp mometasone furoate 0.1% w/w lotion bottle

medis pharma pty ltd - mometasone furoate, quantity: 1 mg/g - lotion - excipient ingredients: monobasic sodium phosphate; phosphoric acid; propylene glycol; hyprolose; isopropyl alcohol; purified water - short-term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, such as psoriasis and atopic dermatitis. the lotion is also suitable for short-term use for scalp psoriasis and seborrhoeic dermatitis.

MOMETASONE-GX mometasone furoate 0.1% w/w lotion bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

mometasone-gx mometasone furoate 0.1% w/w lotion bottle

medis pharma pty ltd - mometasone furoate, quantity: 1 mg/g - lotion - excipient ingredients: monobasic sodium phosphate; phosphoric acid; propylene glycol; hyprolose; isopropyl alcohol; purified water - short-term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, such as psoriasis and atopic dermatitis. the lotion is also suitable for short-term use for scalp psoriasis and seborrhoeic dermatitis.

MOMETASONE MEDIS mometasone furoate 0.1% w/w lotion bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

mometasone medis mometasone furoate 0.1% w/w lotion bottle

medis pharma pty ltd - mometasone furoate, quantity: 1 mg/g - lotion - excipient ingredients: monobasic sodium phosphate; phosphoric acid; propylene glycol; hyprolose; isopropyl alcohol; purified water - short-term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, such as psoriasis and atopic dermatitis. the lotion is also suitable for short-term use for scalp psoriasis and seborrhoeic dermatitis.

SANDOZ MOMETASONE SPRAY, METERED DOSE Canada - Engels - Health Canada

sandoz mometasone spray, metered dose

sandoz canada incorporated - mometasone furoate (mometasone furoate monohydrate) - spray, metered dose - 50mcg - mometasone furoate (mometasone furoate monohydrate) 50mcg - corticosteroids